The devices in question are the Whoop 5.0 and the Whoop MG, both of which require you to ... no-nonsense wearables with an estimated 14-day battery life and 10 times the power efficiency of ...

On Tuesday, Health Canada issued alerts for one lot of Laboratoire Riva Inc.’s acetaminophen 500 milligram caplet and six lots of Life Brand’s Timed Release Melatonin 10 mg tablet. Health ...

demonstrating a 14% reduction in risk of major adverse cardiovascular events (MACE) in adults with type 2 diabetes and CVD and/or CKD when treated with Rybelsus ® compared to placebo. Each ...

The SOUL trial achieved its primary endpoint, demonstrating a 14% reduction in risk of major adverse cardiovascular events (MACE) in adults with type 2 diabetes and CVD and/or CKD when treated with ...

Rybelsus ® reduced major adverse cardiovascular events by 14% vs placebo in adults with type 2 diabetes and cardiovascular and/or chronic kidney disease in the SOUL cardiovascular outcomes trial 1.

Rybelsus ® reduced major adverse cardiovascular events by 14% vs placebo in adults with type 2 diabetes and cardiovascular and/or chronic kidney disease in the SOUL cardiovascular outcomes trial 1.

Bagsværd, Denmark, 29 March 2025 – Novo Nordisk today presented the full results from the SOUL cardiovascular outcomes trial, demonstrating that Rybelsus ® (oral semaglutide) significantly ...

At the start of treatment, the dexamethasone tablet dosage for adults with inflammation ranges from 0.75 mg to 9 mg per day, depending on the specific condition causing inflammation. Your doctor ...

Global pharma major Lupin Limited (Lupin) announced that it has launched rivaroxaban tablets USP, 2.5 mg, following the final approval of its Abbreviated New Drug Application from the US FDA.